News
President Trump fired new salvos in the global trade war, threatening a 50% tariff on imported goods from the European Union and new duties on iPhones and other smartphones made overseas. Dow ...
Funds from State Street, American Funds, and Invesco are among the best performers. Large-blend mutual funds are the ...
The spotlight was back on U.S. supply chains heading into the Memorial Day weekend after President Donald Trump threatened a "straight" 50% tariff on the European Union and at least a 25% levy on ...
I'm older than your daughter's boyfriend and, possibly, younger than you, so I can give you some perspective from both vantage points. I think he is a chancer - an opportunist - to charge you a fee ...
The S&P/TSX Composite Index is down 91.98 points or 0.35% this week to 25879.95 --Largest one-week point and percentage decline since the week ending April 4, 2025 ...
The IPC Indice de Precios Y Cotizaciones is up 423.23 points or 0.73% this week to 58410.37 --Largest three-week point and percentage gain since the week ending May 9, 2025 ...
Regarding phone makers, Trump said Apple Inc. (AAPL) will face an import tax of "at least 25%" on any iPhones not made in the U.S. Later in the day, he said his trade action would extend to Samsung ...
Iona University will receive $74.7 million from the sale of tax-exempt municipal bonds, with the proceeds going to support construction projects and pay off existing debt.
As a revenue source, tariffs are unlikely to be sufficient to balance a multi-trillion-dollar U.S. deficit. Because tariffs are expected to be transitory, the deficit for a while will likely decline, ...
These eight words are generally not allowed in marketing materials: best, worst, most, least, highest, lowest, always and never.
Tandem Diabetes Care has agreed to pay Roche Holding $36 million to settle a patent infringement claim. The two companies have granted each other licenses to patents on the insulin delivery systems in ...
Health-care companies fell, but not by as much as the broad market, as the defensive bias on the stock market bolstered two new issues in the sector. Shares of Chinese drugmaker Jiangsu Hengrui ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results